In the News
Four Internal Medicine specialties ranked by U.S. News & World Report
U.S. News & World Report’s annual Best Hospitals listings released today. UT Southwestern Medical Center has retained its listing as the No. 1-ranked hospital in Dallas-Fort Worth and No. 2 in Texas. Four of Internal Medicine specialties ranked nationally out of 4,500 medical centers evaluated nationwide for 2018-2019:
New cardiovascular risk calculator
A team of researchers led by cardiologists at UT Southwestern Medical Center has developed a new online tool to more accurately predict who among those ages 40-65 is at the highest risk of suffering a heart attack or stroke in the next 10 years.
The new tool, named the Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) calculator, was developed by the National Space Biomedical Research Institute (NSBRI) together with a research team led by UT Southwestern preventive cardiologist.
Searching for metabolic signs of heart problems
Oncologists have known for more than half a century that anthracyclines, a class of drugs used to treat solid tumors, can cause damage to the heart.
Dr. Vlad Zaha, Assistant Professor of Internal Medicine at UT Southwestern and a member of the Harold C. Simmons Comprehensive Cancer Center, is a cardiologist who specializes in heart problems caused by cancer treatment. He was recently awarded a $2.3 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to study the metabolic changes that occur in the heart with anthracycline treatment.
Dr. de Lemos honored with ROTO Award
Cardiologist Dr. James de Lemos, Professor of Internal Medicine, and pediatrician Dr. Dorothy Sendelbach, Assistant Dean of Undergraduate Medical Education at UT Southwestern, have been recognized with the UT System’s highest educational honor, the Regents’ Outstanding Teaching Awards, for their academic prowess and mentoring talent.
UTSW ranked No. 1 for published research
UT Southwestern Medical Center is the No. 1 academic medical center in the world for publishing high-quality scientific research, according to the Nature Index 2018 Annual Tables released today. UT Southwestern is ranked first among peer institutions that include Columbia University Medical Center, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, and UC San Diego Health.
Hobbs awarded Institut de France Grand Prix
UT Southwestern Medical Center geneticist Dr. Helen Hobbs is the 2018 recipient of the Institut de France Grand Prix Scientifique.
The Lefoulon-Delalande Grand Prize in Science, one of the largest awards for scientific achievement and considered one of the most prestigious prizes in the world in cardiovascular research, was awarded to Dr. Hobbs, an Investigator of the Howard Hughes Medical Institute, for her role in the discovery of a novel way to reduce cholesterol.
MRSA infections less costly, but still deadly
Staph infections, whether MRSA (resistant to methicillin) or susceptible, are important and deadly. Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly less, a new national analysis shows.
“The lower costs for treating drug-resistant infections were a surprise,” said Dr. Trish Perl, Chief of Infectious Diseases and Geographic Medicine and a co-author of the study. “The findings are contrary to previous predictions and studies that suggested the treatment costs for drug-resistant infections would be greater.”
Financial strain has major impact on patients’ health care decisions
Financial strain is the single most important factor in making health care decisions for low-income individuals, who often forgo care in favor of basic needs like food and rent, researchers in UT Southwestern’s Center for Patient-Centered Outcomes Research (PCOR) found.
“Financial strain is the burden that prevents many low-income patients from being able to take better care of themselves,” said lead author Dr. Oanh Nguyen, Assistant Professor of Internal Medicine and Clinical Sciences at UT Southwestern Medical Center. “This financial strain can cause nonadherence to physician recommendations that appear to reflect a patient’s lack of engagement in care. However, this ‘nonadherence’ is actually the result of rational and difficult trade-offs to cope with financial strain.”
Dr. Gerber commentary on clinical trial exclusions
The growing number of exclusions is shrinking the pool of candidates who can participate in trials and causing delays in drug development. Currently, fewer than 2 percent of adult cancer patients in the United States are treated in clinical trials. And research by Dr. David Gerber shows that patients with a history of cancer are excluded in more than 80 percent of lung cancer trials.
Dr. Ambarish Pandey selected Texas Health Resources Clinical Scholar
UT Southwestern cardiologist Dr. Ambarish Pandey has been named a Texas Health Resources Clinical Scholar. Funding from this award will bolster his studies developing novel approaches to prevent heart failure and improve heart failure outcomes at a health system level.
The $750,000 career development award over three years supports Dr. Pandey’s research on screening and prevention of heart failure, particularly heart failure with preserved ejection fraction, a difficult to treat form of heart failure.